Keywords: کاندزارتان; Stroke; Neurorestoration; Neurovascular remodeling; White matter remodeling; Synaptogenesis; Stem cell therapy; Mesenchymal stromal cells; Umbilical cord blood cells; MicroRNA; Minocycline; Candesartan;
مقالات ISI کاندزارتان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کاندزارتان; amlodipine; candesartan; combination; hypertension;
Keywords: کاندزارتان; Hydrochlorothiazide; Irbesartan; Candesartan; Spectrophotometry; MCR; CRACLS;
Keywords: کاندزارتان; Candesartan; Mania; Antioxidant; Anti-inflammatory; BDNF; GSK3beta;
Keywords: کاندزارتان; Diabetic nephropathy; Candesartan; Spironolactone; Oxidative stress;
Keywords: کاندزارتان; Angiotensin; Candesartan; l-DOPA; Neuroprotection; Parkinson; Serotonin5-HIAA, metabolite 5-hydroxyindolacetic acid; 5-HT, serotonin; 6-OHDA, 6-hydroxydopamine; AII, angiotensin II; AT1, angiotensin type-1 receptor; AT2, angiotensin type-2 receptor; AUC,
Keywords: کاندزارتان; Candesartan; Heart failure; Angiotensin II receptor blocker; Brain natriuretic peptide; Left ventricular ejection fraction;
Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux
Keywords: کاندزارتان; Candesartan; Autophagy; TRAIL; Apoptosis; Lung cancer cells; DR5; AMPK;
Candesartan, angiotensin II type 1 receptor blocker is able to relieve age-related cognitive impairment
Keywords: کاندزارتان; Candesartan; Aging; Passive avoidance; Object recognition test; Learning; Memory;
Short-term Heat Exposure Promotes Hippocampal Neurogenesis via Activation of Angiotensin II Type 1 Receptor in Adult Rats
Keywords: کاندزارتان; AGT; angiotensinogen; Ang II; angiotensin II; AT1R; Ang II type 1 receptor; AT2R; Ang II type 2 receptor; BDNF; brain-derived neurotrophic factor; CONT; control; DCX; doublecortin; GFAP; glial fibrillary acidic protein; HEAT; heat exposure; PBS; phosphate
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy
Keywords: کاندزارتان; Angiotensin II; Candesartan; Irbesartan; Valsartan; Telmisartan;
A precision-guided MWNT mediated reawakening the sunk synergy in RAS for anti-angiogenesis lung cancer therapy
Keywords: کاندزارتان; Multi-walled carbon nanotube; Dual-targeting to lung cancer; RAS related synergistic therapy; Candesartan; Plasmid AT2; Anti-angiogenesis therapy;
Determination of azide impurity in sartans using reversed-phase HPLC with UV detection
Keywords: کاندزارتان; Azide; HPLC-UV; Sartans; Irbesartan; Candesartan; Valsartan; Genotoxic impurity;
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway
Keywords: کاندزارتان; Angiotensin II; Liver cancer; AT1R antagonist; Candesartan; Tumor angiogenesis; Hepatocytes;
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension
Keywords: کاندزارتان; angiotensin receptor blocker; candesartan; fimasartan; hypertension;
MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2–angiotensin-(1-7)–MAS axis functionality
Keywords: کاندزارتان; Early atherosclerosis; AT1 receptors; Angiotensin-converting-enzyme 2; Angiotensin-(1-7); MAS receptors; Candesartan
Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade
Keywords: کاندزارتان; Candesartan; Glycyrrhizin; MCAO; TLR
A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy
Keywords: کاندزارتان; Multifunctional copolymer-anticancer conjugate; Candesartan; Wild type p53; Angiotensin II type 1 receptor targeting; Co-delivery; Tumor anti-angiogenesis therapy;
Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: A subanalysis of the HIJ-CREATE study
Keywords: کاندزارتان; Coronary artery disease; Hypertension; Combination therapy; Amlodipine; Candesartan;
Keywords: کاندزارتان; angiotensin II receptor blockers; candesartan; hypertension; therapeutic interchange
Role of angiotensin II type 1 receptors in the subfornical organ in the pressor responses to central sodium in rats
Keywords: کاندزارتان; Subfornical organ; CSF [Na+]; Candesartan; Intra SFO infusion; Ang II; Na+-rich aCSF; Electrolytic lesion
New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets
Keywords: کاندزارتان; Spectrophotometric analysis; Ratio spectra; Atorvastatin; Ezetimibe; Candesartan; Hydrochlorothiazide
Improvement of the antihypertensive capacity of candesartan and trityl candesartan by their SOD mimetic copper(II) complexes
Keywords: کاندزارتان; Antihypertensive drugs; Candesartan; Copper complexes; Antioxidants; Human mesangial contractile cells
Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression
Keywords: کاندزارتان; ARBs; Angiotensin II type 1 receptor blockers; TAC; transverse aortic constriction; AF; atrial fibrillation; EMT; Epithelial-to-mesenchymal transition; MMPs; matrix metalloproteinases; LVAWD and LVPWD; left ventricular anterior and posterior wall at end-d
Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
Keywords: کاندزارتان; Pioglitazone; Candesartan; Human plasma; Solid-phase extraction; LC-MS/MS; Pharmacokinetics
Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression
Keywords: کاندزارتان; Angiotensin II; Angiotensin II type 1 receptor; Candesartan; Retinal neovascularization; Vascular endothelial growth factor;
Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats
Keywords: کاندزارتان; Solid lipid nanoparticles; Candesartan; Oral bioavailability; Lymphatic transport
Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism
Keywords: کاندزارتان; Candesartan cilexetil; Candesartan; Nanoemulsion; Oral absorption
Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system
Keywords: کاندزارتان; Astrocytes; BBB; Inflammation; Neurodegeneration; AT1; AT2; Leukocyte infiltration; Candesartan
Phase IV, 8-Week, Multicenter, Randomized, Active Treatment–Controlled, Parallel Group, Efficacy, and Tolerability Study of High-Dose Candesartan Cilexetil Combined With Hydrochlorothiazide in Korean Adults With Stage II Hypertension
Keywords: کاندزارتان; candesartan; combination; hydrochlorothiazide; hypertension
Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus
Keywords: کاندزارتان; Adiponectin; Angiotensin II type 1 receptor blockers; Candesartan; Telmisartan; Valsartan
Renin-Angiotensin System Blockade Safely Reduces Blood Pressure in Patients With Minor Ischemic Stroke During the Acute Phase
Keywords: کاندزارتان; Acute ischemic stroke; antihypertensive treatment; candesartan; perindopril; neurologic symptoms
Central angiotensin II stimulates cutaneous water intake behavior via an angiotensin II type-1 receptor pathway in the Japanese tree frog Hyla japonica
Keywords: کاندزارتان; Anuran; tree frog; water-absorption behavior; Ang II; Angiotensin type-1 receptor; osmoregulation; Candesartan
Expressions of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Gastric Ischemia-Reperfusion: Role of Angiotensin II
Keywords: کاندزارتان; angiotensin II; ischemia-reperfusion; iNOS; COX-2; candesartan; PD123319; captopril
Long-term effects of candesartan and amlodipine on cardiovascular mortality and morbidity in Japanese high-risk hypertensive patients: Rationale, design, and characteristics of candesartan antihypertensive survival evaluation in Japan extension (CASE-J Ex
Keywords: کاندزارتان; CASE-J; Candesartan; Amlodipine; Cardiovascular events; Diabetes mellitus;
Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway
Keywords: کاندزارتان; Toll-like receptor; Angiotensin II; Mesangial cell; Apoptosis; Candesartan; Oxidative stress
Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry
Keywords: کاندزارتان; On-line solid phase extraction; Mass spectrometry; High throughput; Valsartan; Candesartan
Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study
Keywords: کاندزارتان; Hypertension; Diabetes mellitus; Candesartan; Cardiovascular disease; Challenge-DM study
TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension
Keywords: کاندزارتان; Prehypertension; candesartan; placebo; clinical trials
Effect of renin–angiotensin aldosteron system blockers on postoperative atrial fibrillation
Keywords: کاندزارتان; Cardiopulmonary bypass; Atrial fibrillation; Angiotensin converting-enzyme inhibitors; Candesartan
Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
Keywords: کاندزارتان; Breast cancer cell; Angiogenesis; Angiotensin II; Inhibition; Candesartan
Enzyme-assisted synthesis and structure characterization of glucuronic acid conjugates of losartan, candesartan, and zolarsartan
Keywords: کاندزارتان; Losartan; Candesartan; Zolarsartan; GR117289; Glucuronide; Biosynthesis; Regioisomer
The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan
Keywords: کاندزارتان; Losartan; Candesartan; Zolarsartan (GR117289); UDP-glucuronosyltransferases; Substrate specificity; Tetrazole
Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade
Keywords: کاندزارتان; reactive oxygen species; angiotensin II type 1 receptor blocker; inflammation; redox-sensitine nuclear factor κB; candesartan
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria
Keywords: کاندزارتان; Microalbuminuria; diabetes; hypertension; candesartan; manidipine;
Cooperative effect of angiotensin AT1 and endothelin ETA receptor antagonism limits the brain damage after ischemic stroke in rat
Keywords: کاندزارتان; Angiotensin AT1 receptor; Endothelin ETA receptor; Candesartan; ZD1611; Cerebral ischemia; (Rat)
Beneficios adicionales del tratamiento con candesartán en la insuficiencia cardÃaca. Programa CHARM
Keywords: کاندزارتان; insuficiencia cardÃaca; antagonistas de los receptores de la angiotensina II (ARA II); candesartán; diabetes; fibrilación auricular; infarto de miocardio; heart failure; angiotensin-II receptor antagonists; candesartan; diabetes; atrial fibrillation; m
Angiotensin receptor blockade in diabetic renal disease—Focus on candesartan
Keywords: کاندزارتان; Diabetic nephropathy; Microalbuminuria; Angiotensin receptor blockers; Candesartan
Prospects for angiotensin receptor blockers in diabetic retinopathy
Keywords: کاندزارتان; Diabetes; Retinopathy; Renin–angiotensin system; Candesartan
ARA-II en la insuficiencia cardiaca con función sistólica normal. ¿Dónde estamos y adónde vamos?
Keywords: کاندزارتان; Insuficiencia cardiaca; Función sistólica normal; Candesartán; Heart failure; Normal systolic function; Candesartan;